Related Experiment Videos
Dietary beta-cryptoxanthin and inflammatory polyarthritis: results from a population-based prospective study
Dorothy J Pattison1, Deborah P M Symmons, Mark Lunt
1Arthritis Research Campaign Epidemiology Unit, The University of Manchester, Manchester, United Kingdom.
The American Journal of Clinical Nutrition
|August 10, 2005
Summary
Dietary carotenoids like zeaxanthin and beta-cryptoxanthin may reduce the risk of inflammatory polyarthritis (IP). Higher intake of these antioxidants was linked to a lower incidence of IP, suggesting a protective role in inflammation.
Area of Science:
- Nutritional Epidemiology
- Inflammation Research
- Carotenoid Metabolism
Background:
- Dietary carotenoids possess antioxidant properties potentially mitigating inflammation.
- Oxidative damage is implicated in the pathogenesis of inflammatory conditions.
Purpose of the Study:
- To investigate the association between dietary carotenoid intake and the risk of developing inflammatory polyarthritis (IP).
Main Methods:
- Prospective cohort study (EPIC-Norfolk) with >25,000 participants.
- Dietary carotenoid intake assessed via 7-day food diaries.
- Nested case-control analysis comparing carotenoid intake in IP cases and controls.
Main Results:
- Lower mean intakes of zeaxanthin and beta-cryptoxanthin observed in IP cases compared to controls.
- Increased intake of zeaxanthin and beta-cryptoxanthin associated with reduced risk of IP.
- Beta-cryptoxanthin intake showed a significant inverse association with IP risk, even after adjustments.
Conclusions:
- Findings support a potential protective role for dietary carotenoids, particularly beta-cryptoxanthin, against inflammatory polyarthritis.
- Increased beta-cryptoxanthin intake may lower the risk of developing inflammatory disorders like rheumatoid arthritis.
Related Concept Videos
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...